Chong Kun Dang Holdings Corp.

KSE 001630.KS

Chong Kun Dang Holdings Corp. EBIT Margin for the year ending December 31, 2023: 1.93%

Chong Kun Dang Holdings Corp. EBIT Margin is 1.93% for the year ending December 31, 2023, a 159.90% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Chong Kun Dang Holdings Corp. EBIT Margin for the year ending December 31, 2022 was -3.23%, a -186.83% change year over year.
  • Chong Kun Dang Holdings Corp. EBIT Margin for the year ending December 31, 2021 was 3.72%, a -64.19% change year over year.
  • Chong Kun Dang Holdings Corp. EBIT Margin for the year ending December 31, 2020 was 10.38%, a -13.20% change year over year.
  • Chong Kun Dang Holdings Corp. EBIT Margin for the year ending December 31, 2019 was 11.96%, a 18.29% change year over year.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
SV Wall Street
KSE: 001630.KS

Chong Kun Dang Holdings Corp.

CEO Tae Young Kim
IPO Date Jan. 4, 2000
Location South Korea
Headquarters 8, Chungjeong-ro
Employees 37
Sector Healthcare
Industries
Pharmaceuticals Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Personal Care Soft Drinks & Sodas
Description

Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. The company was founded in 1941 and is headquartered in Seoul, South Korea.

StockViz Staff

February 4, 2025

Any question? Send us an email